Prevalence of primary immune thrombocytopenia in Oklahoma

American Journal of Hematology

Volumn 87, Issue 9, 2012, Pages 848-852

  Terrell, Deirdra R ^a   Beebe, Laura A ^a   Neas, Barbara R ^a   Vesely, Sara K ^a   Segal, Jodi B ^b   George, James N ^a,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEMATOLOGIST; HUMAN; ICD-9-CM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; OKLAHOMA; PREVALENCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEX FACTORS; YOUNG ADULT;

EID: 84865352144     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23262     Document Type: Article

References (28)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura (ITP) in adults and children. Report from an international working group. Blood 2009; 113: 2386-2393.
2. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-186.
3. Neunert CE, Lim W, Crowther MA, et al. The American Society of Hematology 2011 evidenced-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
4. Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549-2554.
5. Neylon AJ, Saunders PWG, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122: 966-974.
6. Mathias SD, Gao SK, Miller KL, et al. Impact of chronic immune thrombocytopenic purpura on health-realted quality of life a conceptual model starting with the patient perspective. Health and Quality of Life Outcomes 2008; 6: 13.
7. Guidry JA, George JN, Vesely SK, et al. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: Patient and hematologist perspectives. Eur J Haematol 2009; 83: 175-182.
8. Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 2011; 86: 420-429.
9. Snyder CF, Mathias SD, Cella D, et al. Health-related quality of life of immune thrombocytopenic purpura patients: Results from a web-based survey. Curr Med Res Opin 2008; 24: 2767-2776.
10. George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: Results from two randomized, placebo-controlled trials. Br J Haematol 2008; 144: 409-415.
11. Imbach P, Kuhne T, Muller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the intercontinental childhood ITP study group (ICIS). Pediatr Blood Cancer 2005; 1-6.
12. Schoonen WM, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 2009; 145: 235-244.
13. Abrahamson PE, Hall SA, Feudjo-Tepie M, et al. The incidence of idiopathic thrombocytopenic purpura among adults: A population-based study and literature review. Eur J Haematol 2009; 83: 83-89.
14. Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: Analysis of a large US claim database: A rebuttal. J Thromb Haemost 2008; 6: 711-712.
15. Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Amer J Hematol 2010; 85: 174-180.
16. Hedman A, Henter JI, Hedlund I, et al. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr 1997; 86: 226-227.
17. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: Analysis of administrative data. J Thromb Haemost 2006; 4: 2377-2383.
18. Bennett D, Hodgson ME, Shukla A, et al. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom. Adv Ther 2011; 28: 1096-1104.
19. Terrell DR, Beebe LA, Vesely SK, et al. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol 2012, in press.
20. Kühne T, Imbach P, Bolton-Maggs PHB, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet 2001; 358: 2122-2125.
21. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediat 2002; 141: 253-258.
22. Census factfinder. Census.gov. 2001. 6-25-2008. Ref Type: Electronic Citation
23. Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation study. Am J Hematol 2004; 75: 12-17.
24. Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 1995; 72: 125-128.
25. Zeller B, Helgestad J, Hellebostad M, et al. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration. Pediatric Hematol Oncol 2000; 17: 551-558.
26. George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Southern Med J 2007; 100: 512-514.
27. Frederiksen H, Schmidt K. The incidence of ITP in adults increases with age. Blood 1999; 94: 909-913.
28. Terrell DR, Beebe LA, George JN, et al. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood 2009; 113: 4126-4127.